Triple
T21327539
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Larry Bock |
E525800
|
entity |
| Predicate | coFounded |
P104
|
FINISHED |
| Object | Neurocrine Biosciences |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Neurocrine Biosciences | Statement: [Larry Bock, coFounded, Neurocrine Biosciences]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Neurocrine Biosciences Context triple: [Larry Bock, coFounded, Neurocrine Biosciences]
-
A.
Alkermes
Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.
-
B.
Mapp Biopharmaceutical
Mapp Biopharmaceutical is a U.S.-based biotechnology company best known for developing antibody-based therapies for infectious diseases, including experimental treatments for Ebola.
-
C.
BioMarin Pharmaceutical
BioMarin Pharmaceutical is a biotechnology company specializing in developing and commercializing therapies for rare genetic diseases.
-
D.
Vertex Pharmaceuticals
Vertex Pharmaceuticals is a biotechnology company best known for developing transformative therapies for cystic fibrosis and other serious diseases using a precision medicine approach.
-
E.
Biogen
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Neurocrine Biosciences Target entity description: Neurocrine Biosciences is a biopharmaceutical company specializing in the discovery and development of treatments for neurological and endocrine-related disorders.
-
A.
Alkermes
Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.
-
B.
Mapp Biopharmaceutical
Mapp Biopharmaceutical is a U.S.-based biotechnology company best known for developing antibody-based therapies for infectious diseases, including experimental treatments for Ebola.
-
C.
BioMarin Pharmaceutical
BioMarin Pharmaceutical is a biotechnology company specializing in developing and commercializing therapies for rare genetic diseases.
-
D.
Vertex Pharmaceuticals
Vertex Pharmaceuticals is a biotechnology company best known for developing transformative therapies for cystic fibrosis and other serious diseases using a precision medicine approach.
-
E.
Biogen
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e0b51b90788190a4dd823d962626da |
completed | April 16, 2026, 10:08 a.m. |
| NER | Named-entity recognition | batch_69e7ab4d69b4819088649e34213d0b67 |
completed | April 21, 2026, 4:52 p.m. |
Created at: April 16, 2026, 4:41 p.m.